PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.02%
Revenue growth 1.25-1.5x 3088.T's 3.59%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
1.81%
Gross profit growth under 50% of 3088.T's 6.76%. Michael Burry would be concerned about a severe competitive disadvantage.
2.13%
EBIT growth below 50% of 3088.T's 42.53%. Michael Burry would suspect deeper competitive or cost structure issues.
6.86%
Operating income growth under 50% of 3088.T's 34.56%. Michael Burry would be concerned about deeper cost or sales issues.
1.99%
Net income growth under 50% of 3088.T's 47.69%. Michael Burry would suspect the firm is falling well behind a key competitor.
2.00%
EPS growth under 50% of 3088.T's 52.29%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
2.00%
Diluted EPS growth under 50% of 3088.T's 52.29%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
70.95%
10Y revenue/share CAGR above 1.5x 3088.T's 43.98%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
66.15%
5Y revenue/share CAGR above 1.5x 3088.T's 18.76%. David Dodd would look for consistent product or market expansions fueling outperformance.
36.76%
3Y revenue/share CAGR above 1.5x 3088.T's 6.90%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
100.00%
Positive long-term OCF/share growth while 3088.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
212.66%
Similar net income/share CAGR to 3088.T's 229.07%. Walter Schloss would see parallel tailwinds or expansions for both firms.
73.93%
5Y net income/share CAGR at 75-90% of 3088.T's 88.73%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
37.10%
3Y net income/share CAGR above 1.5x 3088.T's 6.09%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
219.61%
10Y equity/share CAGR above 1.5x 3088.T's 116.16%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
131.65%
5Y equity/share CAGR above 1.5x 3088.T's 39.09%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
64.76%
3Y equity/share CAGR above 1.5x 3088.T's 19.96%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
77.71%
AR growth well above 3088.T's 17.13%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.23%
Inventory shrinking or stable vs. 3088.T's 5.82%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.13%
Positive asset growth while 3088.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.84%
Positive BV/share change while 3088.T is negative. John Neff sees a clear edge over a competitor losing equity.
57.98%
Debt growth of 57.98% while 3088.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
0.69%
SG&A growth well above 3088.T's 1.24%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.